- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 5th, 2005
As nanotechnology companies move into public markets, early stage companies may lack the revenue visibility usually accompanying startups in more established industries.
It is arguable that a platform technology-based nanotechnology company what well call pluripotent deserves a premium valuation: one that exceeds the value of its visible product line. But as shown by the withdrawn IPO of Nanosys an example of this type of company public investors may not see it this way.
|Related News Press|
Arrowhead to Present at Upcoming Conferences October 8th, 2015
Accelerator Corporation Completes $62.8 Million Oversubscribed Financing September 30th, 2015